Check Y. Quon - Concepedia

Author

Check Y. Quon

DuPont (United States)

Also Known As

C Y Quon, C. Quon, C. Y. QUON, C. Y. Quon, C.Y. Quon, Check Quon, Check Y. Quon

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

DuPont (United States)Wilmington University Merck & Co., Inc., Rahway, NJ, USA (United States)Waukegan Public Library Boston University

About

Check Y. Quon is an author at DuPont (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	417
2	Anesthesia	3	3	101
3	Biochemistry	3	3	64
4	Natural Sciences	1	1	25
5	Social Sciences	1	1	97

Check Y. Quon

Publications

Citations

H-Index

Page 1

	Year	Citations
Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies Amyé Tevaarwerk, Kyle D. Holen, Dona Alberti, Clinical Cancer Research	2009	124
Activity of 2 methoxyestradiol (Panzem® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial Daniela Matei, Jeanne M. Schilder, Gregory P. Sutton, Gynecologic Oncology Panzem® NcdMedicineGynecologyPlatinum-resistant Ovarian CancerCancer Treatment	2009	102
PT‐141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction Perry B. Molinoff, A. M. Shadiack, Dennis Earle, Annals of the New York Academy of Sciences Synthetic Peptide AnalogueSexual HealthUrologyErectile DysfunctionPharmacology	2003	97
Biochemical properties of blood esmolol esterase. Check Y. Quon, Herman F. Stampfli Drug Metabolism and Disposition	1985	79
Pharmacology and Pharmacokinetics of Esmolol Robert D. Reynolds, Richard J. Gorczynski, Check Y. Quon The Journal of Clinical Pharmacology Esmolol InfusionHeart FailureEsmolol AllowsMedicinePhysiology	1986	71
Synthesis, Corticotropin-Releasing Factor Receptor Binding Affinity, and Pharmacokinetic Properties of Triazolo-, Imidazo-, and Pyrrolopyrimidines and -pyridines Robert J. Chorvat, Rajagopal Bakthavatchalam, James P. Beck, Journal of Medicinal Chemistry	1999	63
Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Check Y. Quon, K Mai, Gayatri R. Patil, Drug Metabolism and Disposition	1988	60
Safety, Tolerance and Pharmacokinetics of Intravenous Doses of the Phosphate Ester of 3‐Hydroxymethyl‐5,5‐Diphenylhydantoin: A New Prodrug of Phenytoin Nicolas U. Gerber, D C Mays, Atul Laddu, The Journal of Clinical Pharmacology	1988	57
Clinical pharmacokinetics and pharmacodynamics of colloidal plasma volume expanders Check Y. Quon Journal of Cardiothoracic Anesthesia PharmacologyClinical PharmacokineticsColloidal System	1988	52
The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog. David D. Christ, P C Wong, Y. Nancy Wong, Journal of Pharmacology and Experimental Therapeutics	1994	52

Page 1